BOARD CERTIFICATION EXAM STUDY GUIDES Lower Extremity Trauma
[Click on Image to Enlarge]
ME-P Free Advertising Consultation
The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]
Medical & Surgical e-Consent Forms
ePodiatryConsentForms.com
iMBA Inc., OFFICES
Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.770.448.0769]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.
ME-P Publishing
SEEKING INDUSTRY INFO PARTNERS?
If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].
Posted on May 31, 2024 by Dr. David Edward Marcinko MBA
What’s Up?
[By staff reporters]
According to Wikipedia, the hemline index is a theory presented by economist George Taylor in 1926. The theory suggests that hemlines on women’s dresses rise along with stock prices.
In good economies, we get such results as miniskirts (as seen in the 1920s and the 1960s), or in poor economic times, as shown by the 1929 Wall Street Crash, hems can drop almost overnight.
Non-peer-reviewed research in 2010 supported the correlation, suggesting that “the economic cycle leads the hemline with about three years”.
***
***
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
Posted on May 31, 2024 by Dr. David Edward Marcinko MBA
MEDICAL EXECUTIVE-POST–TODAY’SNEWSLETTERBRIEFING
***
Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants
“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“
A Partner of the Institute of Medical Business Advisors , Inc.
The prices hospitals charge for their services have long been opaque, but thanks to a 2021 hospital price transparency law, the picture is starting to come slightly into focus. And it turns out, there are some huge disparities in the prices hospitals charge that can’t be attributed to quality of care, according to a recent study from research institute Rand Corporation.
Birkenstock rose 11.65% after announcing beats on earnings and revenue, as well as strong consumer demand despite inflation.
Burlington Stores boomed 17.52% after announcing estimate-beating earnings as well as strong margin growth.
What’s down
Salesforce is down 19.73% after the cloud computing company missed revenue estimates for the first time since 2006 and projected slower sales in the coming quarter. Turns out not even commercials featuring hunky Matthew McConaughey could save the company’s quarter.
UIPath shares plummeted 34.06% after announcing disappointing results and lower forward guidance, and to add insult to injury got hit with an analyst downgrade from Bank of America.
Build-A-Bear Workshop got the stuffing knocked out of it, dropping 13.92% after it missed estimates on both the top and bottom lines.
Hormel sank 9.69% after missing earnings thanks to slower retail sales offsetting higher meat prices, leaving shareholders stuck eating bologna sandwiches for lunch.
Kohl’s dropped 22.88% in its worst day ever after the company announced a terrible quarter and forecast more issues ahead due to customers contending with inflation.
Here’s where the major benchmarks ended:
The S&P 500® index (SPX) fell 31.47 points (0.6%) to 5,235.48; the Dow Jones Industrial Averagedropped 330.06 points (0.9%) to 38,111.48; the NASDAQ Composite® ($COMP) declined 183.50 points (1.1%) to 16,737.08.
The 10-year Treasury note yield (TNX) lost more than 7 basis points to 4.548%.
The CBOE Volatility Index® (VIX) rose 0.19 to 14.47.
Interest-rate-sensitive sectors including banks and utilities were among the stronger performers Thursday, boosted by a pullback in Treasury yields from four-week highs posted earlier in the week. Stocks are still heading for a down week, with the S&P 500 on track for its first weekly decline out of the past six.
Legal cannabis is a booming industry: An estimated $38.4 billion in medical and recreational cannabis was sold in the US in 2023, and that figure is projected to rise to $56.9 billion by 2028. The industry has grown an average of 29.1% per year between 2018 and 2023, according to IBISWorld.
Posted on May 31, 2024 by Dr. David Edward Marcinko MBA
By Staff Reporters
***
***
The Basel AML Index, an annual survey published by the International Centre for Asset Recovery (ICAR) at the Basel Institute of Governance, found that countries are not keeping up with “the evolving financial crimes risk of new technologies,” especially crypto and other digital assets.
Citing Financial Action Task Force (FATF) data covering six years from 2017 to 2023, the report found that only 43% of global jurisdictions surveyed are in technical compliance with international standards for crypto anti-money laundering (AML) measures.
While I was in Omaha attending the BRK annual meeting, I hosted Q&A sessions for my readers. Due to high reader interest, what started out as a simple breakfast get-together turned into two breakfast sessions and an afternoon session. We had so much interest that we were still unable to accommodate all of our readers – we had 200 folks on the waiting list.
I was exhausted, but I really enjoyed answering questions and meeting readers. The upside of this is that we have three video recordings.
Over the next three weeks, I will share the videos from each session. For those who prefer to read, I will also include a lightly edited full transcript.
Posted on May 31, 2024 by Dr. David Edward Marcinko MBA
A TECHNICAL ANALYSIS STOCK TRADING SIGNAL?
By Dr. David Edward Marcinko MBA, MEd CMP
***
DEFINITION: The DeMark indicator (DeM) is a technical analysis oscillator that compares the most recent and previous prices of an asset to measure the demand and the directional trend of the market. It is based on principles promoted by technical analyst Thomas DeMark, who developed it over his nearly 50-year career. It aims to identify potential price reversals and inflection points before the market responds. It can be applied to any asset class, region, time interval, and data set.